MENU
+Compare
SNPHY
Stock ticker: OTC
AS OF
Jul 25 closing price
Price
$11.39
Change
+$0.09 (+0.80%)
Capitalization
3.26B

SNPHY Santen Pharmaceutical Co., Ltd. Forecast, Technical & Fundamental Analysis

Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products... Show more

SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SNPHY with price predictions
Jul 25, 2025

SNPHY sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for SNPHY moved above the 200-day moving average on June 25, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 22, 2025. You may want to consider a long position or call options on SNPHY as a result. In of 118 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SNPHY advanced for three days, in of 241 cases, the price rose further within the following month. The odds of a continued upward trend are .

SNPHY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Moving Average Convergence Divergence Histogram (MACD) for SNPHY turned negative on June 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNPHY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SNPHY entered a downward trend on July 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SNPHY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.529) is normal, around the industry mean (5.632). P/E Ratio (15.601) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.004). Dividend Yield (0.026) settles around the average of (0.161) among similar stocks. P/S Ratio (1.687) is also within normal values, averaging (3.643).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNPHY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

View a ticker or compare two or three
SNPHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

SNPHY paid dividends on July 11, 2024

Santen Pharmaceutical Co., Ltd. SNPHY Stock Dividends
А dividend of $0.11 per share was paid with a record date of July 11, 2024, and an ex-dividend date of March 27, 2024. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
Grand Front Osaka Tower A
Phone
+81 663217000
Employees
4073
Web
http://www.santen.co.jp
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMFGX469.385.64
+1.22%
Vanguard S&P Mid-Cap 400 Growth Idx I
GCSSX25.600.14
+0.55%
Goldman Sachs Small Cap Eq Insghts Svc
RLBGX37.230.08
+0.22%
American Funds American Balanced R6
RGIVX14.55-0.01
-0.07%
ClearBridge Global Infrastructure Inc I
COSSX13.65-0.03
-0.22%
Columbia Overseas Value Inst2

SNPHY and Stocks

Correlation & Price change

A.I.dvisor tells us that SNPHY and SNPHF have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNPHY and SNPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNPHY
1D Price
Change %
SNPHY100%
+0.80%
SNPHF - SNPHY
7%
Poorly correlated
N/A
RHHVF - SNPHY
7%
Poorly correlated
-1.03%
RHHBF - SNPHY
6%
Poorly correlated
-5.37%
RHHBY - SNPHY
5%
Poorly correlated
-1.09%
OTSKY - SNPHY
4%
Poorly correlated
+2.15%
More